Based on the key indicators related to Zimmer Biomet's liquidity, profitability, solvency, and operating efficiency, Zimmer Biomet Holdings may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. As of now, Zimmer Biomet's Cash is decreasing as compared to previous years. The Zimmer Biomet's current Cash And Short Term Investments is estimated to increase to about 726.5 M, while Common Stock Shares Outstanding is projected to decrease to under 164.9 M. Key indicators impacting Zimmer Biomet's financial strength include:
Investors should never underestimate Zimmer Biomet's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Zimmer Biomet's cash flow, debt, and profitability to make informed and accurate decisions about investing in Zimmer Biomet Holdings.
Understanding current and past Zimmer Biomet Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Zimmer Biomet's financial statements are interrelated, with each one affecting the others. For example, an increase in Zimmer Biomet's assets may result in an increase in income on the income statement.
Zimmer Biomet competes with Orthofix Medical, SurModics, Pulmonx Corp, CVRx, and Edwards Lifesciences. Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana. Zimmer Biomet operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 19500 people.
Comparative valuation techniques use various fundamental indicators to help in determining Zimmer Biomet's current stock value. Our valuation model uses many indicators to compare Zimmer Biomet value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Zimmer Biomet competition to find correlations between indicators driving Zimmer Biomet's intrinsic value. More Info.
Zimmer Biomet Holdings is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers reporting about 0.64 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Zimmer Biomet Holdings is roughly 1.56 . As of now, Zimmer Biomet's Return On Equity is decreasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Zimmer Biomet's earnings, one of the primary drivers of an investment's value.
Zimmer Biomet's Earnings Breakdown by Geography
Zimmer Biomet Holdings Systematic Risk
Zimmer Biomet's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Zimmer Biomet volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Zimmer Biomet Holdings correlated with the market. If Beta is less than 0 Zimmer Biomet generally moves in the opposite direction as compared to the market. If Zimmer Biomet Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Zimmer Biomet Holdings is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Zimmer Biomet is generally in the same direction as the market. If Beta > 1 Zimmer Biomet moves generally in the same direction as, but more than the movement of the benchmark.
Zimmer Biomet Thematic Clasifications
Zimmer Biomet Holdings is part of Obamacare Repeal investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Large healthcare related equities associated with Obamacare. Healthcare and drug manufacturing companies that will most likely be affected by the final stages of Obamacare repeal
This theme covers Large healthcare related equities associated with Obamacare. Healthcare and drug manufacturing companies that will most likely be affected by the final stages of Obamacare repeal. Get More Thematic Ideas
Today, most investors in Zimmer Biomet Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Zimmer Biomet's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Zimmer Biomet growth as a starting point in their analysis.
Along with financial statement analysis, the daily predictive indicators of Zimmer Biomet help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Zimmer Biomet Holdings. We use our internally-developed statistical techniques to arrive at the intrinsic value of Zimmer Biomet Holdings based on widely used predictive technical indicators. In general, we focus on analyzing Zimmer Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Zimmer Biomet's daily price indicators and compare them against related drivers.
When running Zimmer Biomet's price analysis, check to measure Zimmer Biomet's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zimmer Biomet is operating at the current time. Most of Zimmer Biomet's value examination focuses on studying past and present price action to predict the probability of Zimmer Biomet's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zimmer Biomet's price. Additionally, you may evaluate how the addition of Zimmer Biomet to your portfolios can decrease your overall portfolio volatility.